4-(2-fluorophenyl)-6-methyl-2(1-piperazi nyl)thieno(2,3-D) pyrimidine in the treatment of functional bowel disorder

Details for Australian Patent Application No. 2003255712 (hide)

International Classifications

Event Publications

6 November 2003 Complete Application Filed

Priority application(s): 0304648.9 28.02.03 GB; 0216027.3 10.07.02 GB

11 March 2004 Application Open to Public Inspection

Published as AU-B-2003255712

15 March 2007 Application Accepted

Published as AU-B-2003255712

28 June 2007 Opposition Lodged

Dynogen Pharmaceuticals, Inc. has lodged an opposition against Arachnova Therapeutics Ltd.

5 July 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.